Construction and Characterization of Virus-Like Particles: A Review
Identifieur interne : 000C12 ( Main/Exploration ); précédent : 000C11; suivant : 000C13Construction and Characterization of Virus-Like Particles: A Review
Auteurs : Andris Zeltins [Lettonie]Source :
- Molecular Biotechnology [ 1073-6085 ] ; 2013-01-01.
Descripteurs français
English descriptors
- KwdEn :
Abstract
Abstract: Over the last three decades, virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. The analysis of published data reveals that at least 110 VLPs have been constructed from viruses belonging to 35 different families. This review therefore discusses the main principles in the cloning of viral structural genes, the relevant host systems and the purification procedures that have been developed. In addition, the methods that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs are analyzed. Moreover, some of the modifications that are required to construct VLP-based carriers of viral origin with defined properties are discussed, and examples are provided.
Url:
DOI: 10.1007/s12033-012-9598-4
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000850
- to stream Istex, to step Curation: 000830
- to stream Istex, to step Checkpoint: 000074
- to stream Main, to step Merge: 000C14
- to stream Main, to step Curation: 000C12
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Construction and Characterization of Virus-Like Particles: A Review</title><author><name sortKey="Zeltins, Andris" sort="Zeltins, Andris" uniqKey="Zeltins A" first="Andris" last="Zeltins">Andris Zeltins</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E81AFB74FEECC69CB03A1768D549EEAA242390B9</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1007/s12033-012-9598-4</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-H68648B4-F/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000850</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000850</idno><idno type="wicri:Area/Istex/Curation">000830</idno><idno type="wicri:Area/Istex/Checkpoint">000074</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000074</idno><idno type="wicri:doubleKey">1073-6085:2012:Zeltins A:construction:and:characterization</idno><idno type="wicri:Area/Main/Merge">000C14</idno><idno type="wicri:Area/Main/Curation">000C12</idno><idno type="wicri:Area/Main/Exploration">000C12</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Construction and Characterization of Virus-Like Particles: A Review</title><author><name sortKey="Zeltins, Andris" sort="Zeltins, Andris" uniqKey="Zeltins A" first="Andris" last="Zeltins">Andris Zeltins</name><affiliation wicri:level="1"><country xml:lang="fr">Lettonie</country><wicri:regionArea>Latvian Biomedical Research and Study Centre, Ratsupites 1, 1067, Riga</wicri:regionArea><wicri:noRegion>Riga</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Lettonie</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Molecular Biotechnology</title><title level="j" type="sub">Part B of Applied Biochemistry and Biotechnology</title><title level="j" type="abbrev">Mol Biotechnol</title><idno type="ISSN">1073-6085</idno><idno type="eISSN">1559-0305</idno><imprint><publisher>Humana Press Inc</publisher><pubPlace>New York</pubPlace><date type="published" when="2013-01-01">2013-01-01</date><biblScope unit="volume">53</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="92">92</biblScope><biblScope unit="page" to="107">107</biblScope></imprint><idno type="ISSN">1073-6085</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1073-6085</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cloning</term><term>Expression system</term><term>Nanoparticle</term><term>Self-assembly</term><term>Vaccine</term><term>Virus</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Clonage</term><term>Vaccin</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Over the last three decades, virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. The analysis of published data reveals that at least 110 VLPs have been constructed from viruses belonging to 35 different families. This review therefore discusses the main principles in the cloning of viral structural genes, the relevant host systems and the purification procedures that have been developed. In addition, the methods that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs are analyzed. Moreover, some of the modifications that are required to construct VLP-based carriers of viral origin with defined properties are discussed, and examples are provided.</div></front></TEI><affiliations><list><country><li>Lettonie</li></country></list><tree><country name="Lettonie"><noRegion><name sortKey="Zeltins, Andris" sort="Zeltins, Andris" uniqKey="Zeltins A" first="Andris" last="Zeltins">Andris Zeltins</name></noRegion><name sortKey="Zeltins, Andris" sort="Zeltins, Andris" uniqKey="Zeltins A" first="Andris" last="Zeltins">Andris Zeltins</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C12 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C12 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E81AFB74FEECC69CB03A1768D549EEAA242390B9
|texte= Construction and Characterization of Virus-Like Particles: A Review
}}
| This area was generated with Dilib version V0.6.33. |  |